1
Total investments
0
Early stage
0
Mid stage
0
Late stage
5y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Advisor and Investor
Sep 2021
Fathom Radiant is building computer hardware to train neural networks at the human brain-scale and beyond by building a better network. Help us construct the future of machine intelligence.
Our founding team has previously founded startups with more than $500 million in exits. We are well-funded from investors including Khosla Ventures and Founders Fund.
Experience · 4 entries
All (4)
Investments (1)
Founder (2)
2024
Founder @ Stealth Startup
Jan 2024
A network for entrepreneurs building in stealth.
Submit your information here so investors can find you:
harmonic.ai/get-discovered
2021
Advisor and Investor
Sep 2021
Fathom Radiant is building computer hardware to train neural networks at the human brain-scale and beyond by building a better network. Help us construct the future of machine intelligence.
Our founding team has previously founded startups with more than $500 million in exits. We are well-funded from investors including Khosla Ventures and Founders Fund.
2020
Venture Partner
Aug 2020
7% Ventures is an entrepreneur led, network-driven, trans-Atlantic early stage fund. We invest early in technology which is transformative and can monopolize a big market. We support Founders via our extensive network and seek $billion game changing ideas, passing on the lower risk or less ambition opportunities. We love moonshots...
2017
CEO/Co-Founder (YC W18)
Aug 2017
Autonome VR‑therapie die wachtlijsten verkort en resultaten versnelt
De GGZ kampt met lange wachttijden. Psylaris maakt therapie direct schaalbaar met evidence‑based Virtual‑Reality‑modules.
Onze oplossing
Psylaris ontwikkelt autonome VR‑therapieën voor EMDR, Exposure en CGT. Cliënten volgen de sessies zelfstandig, thuis of in de praktijk, terwijl de therapeut in real‑time voortgangsdata ontvangt en de regie houdt.
Het resultaat: tot 40 % minder behandelminuten per traject én snellere symptoomreductie.
Bewezen impact:
● 850+ zorgorganisaties in NL, BE & DE
● 100 000+ VR‑sessies sinds 2021
● Onafhankelijke studies met universiteiten en GGZ‑instellingen bevestigen onze effectiviteit
Onze missie
De druk op de GGZ verlichten zonder de menselijke maat te verliezen. Samen met behandelaren maken we zorg schaalbaar, persoonlijk en toekomstbestendig.